Published On: Tue, Jul 19th, 2022

GSK faces questions over Haleon’s ‘lower’ valuation

DRUGS giant GSK is under scrutiny after its consumer healthcare arm was spun off for at least £10billion less than an offer it rejected.
Daily Express :: City and Business Feed

About the Author

-

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

GSK faces questions over Haleon’s ‘lower’ valuation